Anand Patel, Assistant Professor of Medicine; Medical Director, Inpatient Leukemia Service

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    AbbVie
    Topic: 
    Advisory Board
    Date added: 
    05/04/2023
    Relationship end date: 
    03/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Bristol Myers Squibb
    Topic: 
    Advisory Board
    Date added: 
    05/04/2023
    Relationship end date: 
    12/10/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Pfizer
    Topic: 
    research funding to institution for trial
    Date added: 
    05/04/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Kronos Bio
    Topic: 
    research funding to institution for trial
    Date added: 
    05/04/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Sumitumo
    Topic: 
    research funding to institution for trial
    Date added: 
    05/04/2023
Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice